Latest News & Features
Generics
Danish pharmaceutical company Novo Nordisk has sued Mylan in a US court over a proposed generic of diabetes drug Victoza (liraglutide). 22 August 2019
Big Pharma
A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products. 21 August 2019
Americas
Bayer has agreed to sell its animal health business to US-based Elanco Animal Health for $7.6 billion, as part of its strategic plan to focus on its core life sciences businesses. 21 August 2019
Americas
Amneal and three other generic makers have agreed to pay $1.54 million to settle a class-action lawsuit, which alleged the companies engaged in an unlawful scheme to maintain their monopoly over an Alzheimer’s drug. 20 August 2019
Americas
The US and Europe have reached the same conclusion in more than 90% of marketing authorisation decisions for new medicines, according to a report from the European Medicines Agency. 19 August 2019
Big Pharma
Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit. 16 August 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, August 15, blocked Actavis’s attempt to market a generic version of Nalpropion Pharmaceuticals’ weight-loss drug Contrave. 16 August 2019
Americas
Sanofi secured a win at the US Court of Appeals for the Federal Circuit yesterday, August 14, after the appeals court concluded a lower court lacked authority to invalidate claims of a patent covering a prostate cancer drug. 15 August 2019
Big Pharma
Drugmaker Aspen has offered to pay the UK’s National Health System £8 million to resolve competition concerns. 15 August 2019
Americas
Ireland-based Jazz Pharma has acquired Virginia-based Cavion in a deal that values the clinical-stage biotech company at up to $312.5 million. 14 August 2019